Novo Nordisk A/S agreed to pay United Laboratories International Holdings as much as $2 billion for a next-generation obesity drug, the Danish Ozempic maker’s latest move to refill its pipeline ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese ...

Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

rose as much as 2.3% on Monday. They were up 0.9% at 10:57 a.m. in Frankfurt, valuing the firm at about €312 billion ($338 billion). That tipped it past Novo Nordisk, whose shares have declined ...

LONDON, March 24 (Reuters) - German software company SAP (SAPG.DE), opens new tab overtook Danish healthcare company Novo Nordisk (NOVOb.CO), opens new tab as Europe's largest company by market ...

told the meeting that the promising results justify further research and a larger phase 2 trial is planned for the second half of this year, with results expected in around 2026. Novo Nordisk’s ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

Xenoblade Chronicles X is the Switch game of the moment right now — especially while we're all waiting for the Switch 2. But it emerged yesterday that the game is hiding a 60fps mode.

(Bloomberg) -- The United Steelworkers said an activist investor wants to sell United States Steel Corp.’s state-of-the-art mills to fund sweeping upgrades of union-run facilities that date back ...